共 34 条
Mammalian target of rapamycin regulates IRS-1 serine 307 phosphorylation
被引:127
作者:
Carlson, CJ
White, MF
Rondinone, CM
[1
]
机构:
[1] Abbott Labs, Global Pharmaceut Res Div, Insulin Signaling, Metab Dis Div, Abbott Pk, IL 60064 USA
[2] Harvard Univ, Sch Med, Joslin Diabet Ctr, Howard Hughes Med Inst, Boston, MA 02215 USA
关键词:
signal transduction;
c-Jun NH2 terminal kinase;
3T3-L1;
adipocytes;
insulin;
cellular localization;
PP2A;
okadaic acid;
D O I:
10.1016/j.bbrc.2004.02.082
中图分类号:
Q5 [生物化学];
Q7 [分子生物学];
学科分类号:
071010 [生物化学与分子生物学];
081704 [应用化学];
摘要:
Insulin signaling can be negatively regulated by phosphorylation of serine 307 of the insulin receptor substrate (IRS)-1. Rapamycin, an inhibitor of the kinase mTOR, can prevent serine 307 phosphorylation and the development of insulin resistance. We further investigated the role of mTOR in regulating serine 307 phosphorylation, demonstrating that serine 307 phosphorylation in response to insulin. anisomycin, or tumor necrosis factor was quantitatively and temporally associated with activation of mTOR and could be inhibited by rapamycin. Amino acid stimulation activated mTOR and resulted in IRS-1 serine 307 phosphorylation without activating PKB or JNK. Okadaic acid, an inhibitor of the phosphatase PP2A, activated mTOR and stimulated the phosphorylation of serine 307 in a rapamycin-sensitive manner, indicating serine 307 phosphorylation requires mTOR activity but not PP2A, suggesting that mTOR itself may be responsible for phosphorylating serine 307. Finally, we demonstrated that serine 307 phosphorylated IRS-1 is detected primarily in the cytosolic fraction. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:533 / 539
页数:7
相关论文

